Who
Peter M. Wilver
Director
Company insider
Files Form 4 as: Director, LivaNova; Director, Baxter International; Director, Shoals Technologies Group; Director, Evoqua Water Technologies; Director, Circor International; Director, Tenet Healthcare; Exec. VP & Chief Admin Officer, Thermo Fisher Scientific.
In numbers
- Trades disclosed
- 290
- Buys
- 2
- Sells
- 19
- Bought
- $221K
- Sold
- $67.4M
- Companies
- 7
- Companies where not an officer
- 6
- First trade
- 26 Feb 2006
- Last trade
- 15 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 17 Jun 2026 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code M | —4,042 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code F | $39K486 at $79.70 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,042 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,042 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,383 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,383 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code M | —4,042 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code F | $39K486 at $79.70 | filing |
| 15 Jun 2025filed 17 Jun 2025 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,416 at $0.00 | filing |
| 15 Jun 2025filed 17 Jun 2025 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,042 at $0.00 | filing |
| 15 Jun 2025filed 17 Jun 2025 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code M | —3,416 at $0.00 | filing |
| 15 Jun 2025filed 17 Jun 2025 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code F | $19K410 at $45.76 | filing |
| 15 Jun 2024filed 18 Jun 2024 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,680 at $0.00 | filing |
| 15 Jun 2024filed 18 Jun 2024 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,416 at $0.00 | filing |
| 15 Jun 2024filed 18 Jun 2024 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code M | —2,680 at $0.00 | filing |
| 15 Jun 2024filed 18 Jun 2024 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code F | $31K585 at $52.68 | filing |
| 7 May 2024filed 9 May 2024 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code A | —5,952 at $0.00 | filing |
| 2 May 2024filed 3 May 2024 | SHLS Shoals Technologies GroupSolar & Renewables | SEC FORM 4 Code A | —20,619 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,082 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,680 at $0.00 | filing |
News
Reviewing HealthEquity (NASDAQ:HQY) & Tenet Healthcare (NYSE:THC)THC · themarketsdaily.com · 19 Oct 2026Critical Review: Henry Schein (NASDAQ:HSIC) & Tenet Healthcare (NYSE:THC)THC · tickerreport.com · 16 Oct 2026Tenet Healthcare's Rally Raises a Key Question About Its ValuationTHC · insidermonkey.com · 16 Oct 2026Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences RecoveryTMO · insidermonkey.com · 16 Oct 2026Thermo Fisher Scientific Inc. $TMO Shares Acquired by Artemis Investment Management LLPTMO · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Peter M. Wilver; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.